Major risk factors for Alzheimer's disease: age and genetics.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

1. Golgi dysfunction in Alzheimer disease: from human multiomic signatures to therapeutic targets.Experimental & molecular medicine · 2026
   Review
2. Effect of age-friendly community degree on the cognitive function of older adults.Frontiers in psychiatry · 2026
   Article
3. Advancing Alzheimer's disease risk prediction: development and validation of a machine learning-based preclinical screening model in a cross-sectional study.BMJ open · 2025
   Article
4. Development and validation of the Florey Dementia Risk Score web-based tool to screen for Alzheimer's disease in primary care.EClinicalMedicine · 2024
   Article
5. Pain as a Protective Factor for Alzheimer Disease in Patients with Cancer.Cancers · 2022
   Article
6. Protective effect ofFrontiers in pharmacology · 2022
   Article
7. The Influence of 24-h Ambulatory Blood Pressure on Cognitive Function and Neuropathological Biomarker in Patients With Alzheimer's Disease.Frontiers in aging neuroscience · 2022
   Article
8. Construction of a risk prediction model for Alzheimer's disease in the elderly population.BMC neurology · 2021
   Article
9. Comprehensive Management of Daily Living Activities, behavioral and Psychological Symptoms, and Cognitive Function in Patients with Alzheimer's Disease: A Chinese Consensus on the Comprehensive Management of Alzheimer's Disease.Neuroscience bulletin · 2021
   Review
10. Molecular identification of protein kinase C beta in Alzheimer's disease.Aging · 2020
    Article

Corrections and comments

• Comment on
  Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.2020

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as